Similarly, studies of GLP-1 receptor agonists as add-on to background insulin demonstrated modest reductions in HbA1c (0.2% to 0.4%), an ability to down-titrate background insulin doses, and average weight loss of about 5 kg
Mayo Clin Proc, 2013, 88 (6), 544551
4C,D, IR myotubes with suppressed autophagy showed p-Akt/Akt and GLUT-4 levels significantly decreased
Bimagrumab Bimagrumab is a human monoclonal antibody that stimulates skeletal muscle growth by blocking the activin type II receptor (ActRII) and it is administered as a four-weekly intravenous infusion [96]
Given the difficulty of exogenous drug interventions in penetrating the bloodbrain barrier, several trials on strategies to promote endogenous OT production are underway